This is a clinical research study to learn more about a drug being developed to treat Hidradenitis Suppurativa. The study drug is called 'Povorcitinib.' We want to learn more about how this study drug affects those with Hidradenitis Suppurativa.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Chris Sayed
Dermatology - Adult
Clinical or Medical
Interventional
Skin, Hair, and Nails
22-3258
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
